Silvia Arcangeli

647 citations
14 papers · 331 indexed · h-index 6
Topics
CAR-T cell therapy research (14 papers)Immune Cell Function and Interaction (6 papers)Virus-based gene therapy research (3 papers)
Partner nations
ItalySwitzerlandGermany

In The Last Decade

Silvia Arcangeli

14 papers receiving 327 citations

Peers

Silvia Arcangeli
Comparison fields: 5 of 24
  • Oncology 305
  • Molecular Biology 121
  • Immunology 120
  • Biomedical Engineering 96
  • Genetics 87
Replace Maria Caterina Rotiroti with:
Maria Caterina Rotiroti Italy
Edward Waldron United States
Rashmika Patel United States
Zhuojun Ling China
Jakrawadee Julamanee Thailand
Victoria Shi United States
Minnal Gupta United States
Ko Kudo Japan
Evangelia Kokalaki United Kingdom
Annie Etuk United Kingdom
Silvia Arcangeli relative to Maria Caterina Rotiroti Italy Maria Caterina Rotiroti's profile →
Citations per field
00.5×1.5×1.9×
Maria Caterina Rotiroti · 1×
Citations per year

Countries citing papers authored by Silvia Arcangeli

Since Specialization
Citations

This map shows the geographic impact of Silvia Arcangeli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Silvia Arcangeli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Silvia Arcangeli more than expected).

Fields of papers citing papers by Silvia Arcangeli

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Silvia Arcangeli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Silvia Arcangeli. The network helps show where Silvia Arcangeli may publish in the future.

Co-authorship network of co-authors of Silvia Arcangeli

This figure shows the co-authorship network connecting the top 25 collaborators of Silvia Arcangeli. A scholar is included among the top collaborators of Silvia Arcangeli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Silvia Arcangeli. Silvia Arcangeli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

14 of 14 papers shown
#WorkIndexed citations
1 30
2 96
3 42
4 9
5 1
6 120
7 1
8 2
9 5
10 17
11 2
12 4
13 1
14 1

About Silvia Arcangeli

Silvia Arcangeli is a scholar working on Oncology, Immunology and Genetics, having authored 14 papers that have together received 331 indexed citations. Recurring topics across this work include CAR-T cell therapy research (14 papers), Immune Cell Function and Interaction (6 papers) and Virus-based gene therapy research (3 papers). The work is most often cited by research in Oncology (305 citations), Immunology (120 citations) and Hematology (40 citations). Silvia Arcangeli has collaborated with scholars based in Italy, Switzerland and Germany. Frequent co-authors include Ettore Biagi, Sarah Tettamanti, Maria Caterina Rotiroti, Andrea Biondi, Chiara F. Magnani, Monica Casucci, Chiara Bonini, Luca Simonelli, Luca Varani and Attilio Bondanza. Their work appears in journals such as Blood, Frontiers in Immunology and Molecular Therapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026